Skip to content
Clinical Trials – home
Martin-Luther-Universitaet Halle-Wittenberg
Sponsor

Martin-Luther-Universitaet Halle-Wittenberg

Germany Ernst-Grube-Strasse 40, Kroellwitz, 06120 Halle (Saale), Germany

About the sponsor

Martin-Luther-Universitaet Halle-Wittenberg supports clinical research in progressive well-differentiated metastatic neuroendocrine tumors of the pancreas and myeloproliferative neoplasm in accelerated phase, with an emphasis on treatment response, disease control, and haematologic disease management.

  • Pancreatic neuroendocrine tumors
  • Myelofibrosis and accelerated-phase disease
  • Combination therapy in haematologic malignancy

The sponsor’s funded studies include both solid-tumour and blood-disorder settings, reflecting interest in advanced cancer care and therapies for difficult-to-treat proliferative disorders.

About Specializations

Martin-Luther-Universitaet Halle-Wittenberg runs clinical trials in conditions such as Diabetic retinal oedema, Infertility male, Myelofibrosis, Acoustic neuroma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

6 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:Martin-Luther-Universitaet Halle-Wittenberg
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Follitropin Alfa
  • Sponsor:Martin-Luther-Universitaet Halle-Wittenberg
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Martin-Luther-Universitaet Halle-Wittenberg
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nimodipine
  • Sponsor:Martin-Luther-Universitaet Halle-Wittenberg
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Martin-Luther-Universitaet Halle-Wittenberg
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ramucirumab
  • Sponsor:Martin-Luther-Universitaet Halle-Wittenberg

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.